News
Dr Faduola Dr. Paul Faduola, the Chief Executive Officer (CEO) of Androcare Fertility Centre and Oncogenomics is a medical ...
AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.
Awareness Month, which seeks to raise recognition and push for research of this rare genomic imprinting disorder. PWS is estimated to affect about one in 20 000 individuals1 yet, until now, people ...
After a multi-year process of development and garnering approvals, the new Genetic Counseling Graduate Program at UB has received accreditation from the Accreditation Council for Genetic Counseling ...
The FDA’s approval of Fujirebio’s ‘Lumipulse G' can now be used by doctors to determine whether or not someone has a build-up ...
Researchers at the University of Oklahoma are advancing the fight against inherited retinal diseases (IRDs) with new genetic ...
Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...
Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining ...
Many FDA-regulated companies are exploring ways to support diagnostic testing, especially when early diagnosis can impact treatment options.
While genetic testing has advanced, and has enabled clinicians and doctors to provide families with answers when medical problems arise in children... | Clinical And Molecular Dx ...
The test applies to potentially thousands of different diseases, and it can even detect new ones by providing the evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results